Additionally, SYNJ1-haploinsufficient AD mouse models (with Swedish APP and PSEN1 exon 9 deletion) exhibited a lower plaque load, reduced amyloid peptide levels, and improved cognition. Here, SYNJ1 is linked to Alzheimer disease.